Treatment Strategies for Co-Occurring ADHD and Substance Use Disorders
Open accessThe DOI matches its Crossref record; 109 of the 110 references it cites were found in a registry or an index.
Abstract
Attention‐deficit hyperactivity disorder (ADHD) is a common co‐occurring mental disorder among patients with substance use disorders (SUD). Clinicians must be cognizant of the complicated nature of diagnosis and treatment of ADHD when comorbid with SUD. Pharmacotherapy remains the mainstay of treatment for ADHD, although complementary psychotherapeutic approaches have been developed. Psychostimulant medications are the most commonly used medications to treat ADHD, but many clinicians are reluctant to prescribe stimulants to patients with SUD. Recommendations for treatment planning and clinical management for patients with co‐occurring ADHD and SUD are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Higher doses of prescription psychostimulants were associated with the best outcomes for cocaine use disorder.136”
From The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder (2024) · cites this paper as [136]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A high-quality meta-analysis demonstrated that prescription psychostimulant medications-including modafinil, methylphenidate, MAS-ER, lisdexamfetamine, and dextroamphetamine-were associated with better cocainerelated outcomes, including reported sustained abstinence and cocaine-negative urine drug results. 136”
From The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder (2024) · cites this paper as [136]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“No difference was noted on treatment retention.”
From The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder (2024) · cites this paper as [136]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“a meta-analysis found that MAS-ER and topiramate in combination had positive effects for achieving a period of cocaine abstinence during treatment compared to placebo.136”
From The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder (2024) · cites this paper as [136]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“No difference was noted on treatment retention.”
From The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder (2024) · cites this paper as [136]
Experimental — accuracy not yet measured
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kessler, R. C. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950010008002 · Cited by 12,370
Kessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.617 · Cited by 12,052
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR)
American Psychiatric Association (2000) · doi:10.1176/appi.books.9780890423349 · Cited by 11,069
Goodman & Gilman's The Pharmacological Basis of Therapeutics
Brunton, L. L. (1985) · Cited by 7,321
Goodman and Gilman's the Pharmacological Basis of Therapeutics
Stigelman, W. H., & Pharm, D. (1986) · Military Medicine · doi:10.1093/milmed/151.1.386 · Cited by 6,782
Structured Clinical Interview for DSM-IV Axis I Disorders
Spitzer, R. L., First, M. B., & Gibbon, M. (1997) · Medical Entomology and Zoology · Cited by 4,086
Regier, D. A. (1990) · JAMA · doi:10.1001/jama.1990.03450190043026 · Cited by 3,962
Kessler, R. C., Adler, L., Barkley, R., Biederman, J., Conners, C. K., Demler, O., Faraone, S. V., Greenhill, L. L., Howes, M. J., Secnik, K., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.4.716 · Cited by 3,886
Grant, B. F., Stinson, F. S., Dawson, D. A., Chou, S. P., Dufour, M. C., Compton, W., Pickering, R. P., & Kaplan, K. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.8.807 · Cited by 2,889
The Neural Basis of Addiction: A Pathology of Motivation and Choice
Kalivas, P. W., & Volkow, N. D. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.8.1403 · Cited by 2,757
(1998) · Cited by 2,026
Regier, D. A., Farmer, M. E., Rae, D. S., et al. (1990) · PubMed · Cited by 1,913
Limitations of the Application of Fourfold Table Analysis to Hospital Data
Berkson, J. (1946) · Biometrics Bulletin · doi:10.2307/3002000 · Cited by 1,810
Biederman, J. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.5.816 · Cited by 1,498
Barkley, R. A., Fischer, M., Smallish, L., & Fletcher, K. (2002) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.111.2.279 · Cited by 1,199
Association of attention-deficit disorder and the dopamine transporter gene.
Cook, E. H., Stein, M. A., Krasowski, M. D., Cox, N. J., Olkon, D. M., Kieffer, J. E., & LEVENTHAL, B. L. (1995) · PubMed · Cited by 1,167
Wilens, T. E., Faraone, S. V., Biederman, J., & Gunawardene, S. (2003) · Pediatrics · doi:10.1542/peds.111.1.179 · Cited by 872
Bush, G., Frazier, J. A., Rauch, S. L., Seidman, L. J., Whalen, P. J., Jenike, M. A., Rosen, B. R., & Biederman, J. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00083-9 · Cited by 866
Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies
Michelson, D., Adler, L., Spencer, T., Reimherr, F. W., West, S. A., Allen, A. J., Kelsey, D., Wernicke, J., Dietrich, A., & Milton, D. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01671-2 · Cited by 790
Volkow, N. D., Wang, G.-J., Fowler, J. S., Logan, J., Gerasimov, M., Maynard, L., Ding, Y.-S., Gatley, S. J., Gifford, A., & Franceschi, D. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-02-j0001.2001 · Cited by 770
RASMUSSEN, P., & GILLBERG, C. (2000) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200011000-00017 · Cited by 728
Childhood predictors of adolescent substance use in a longitudinal study of children with ADHD
Molina, B. S. G., & Pelham, W. E. (2003) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.112.3.497 · Cited by 706
Attention deficit hyperactivity disorder adults: Comorbidities and adaptive impairments
Murphy, K., & Barkley, R. A. (1996) · Comprehensive Psychiatry · doi:10.1016/s0010-440x(96)90022-x · Cited by 700
Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder.
LaHoste, G. J., Swanson, J. M., Wigal, S. B., Glabe, C. G., Wigal, T. L., King, N., & Kennedy, J. L. (1996) · PubMed · Cited by 678
Solanto, M. V. (1998) · Behavioural Brain Research · doi:10.1016/s0166-4328(97)00175-7 · Cited by 677
Kessler, R. C., Adler, L. A., Barkley, R., Biederman, J., Conners, C. K., Faraone, S. V., Greenhill, L. L., Jaeger, S., Secnik, K., Spencer, T., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.04.001 · Cited by 663
Comorbidity between DSM-IV alcohol use disorders and major depression: results of a national survey
Grant, B. F., & Harford, T. C. (1995) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(95)01160-4 · Cited by 637
Goodman and Gilman's, The Pharmacological Basis of Therapeutics
DiStefano, V. (1986) · Journal of Pediatric Ophthalmology & Strabismus · doi:10.3928/0191-3913-19860501-17 · Cited by 580
Cognitive-behavioral therapy for ADHD in medication-treated adults with continued symptoms
Safren, S. A., Otto, M. W., Sprich, S., Winett, C. L., Wilens, T. E., & Biederman, J. (2005) · Behaviour Research and Therapy · doi:10.1016/j.brat.2004.07.001 · Cited by 519
Variables That Affect the Clinical Use and Abuse of Methylphenidate in the Treatment of ADHD
Volkow, N. D., & Swanson, J. M. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.11.1909 · Cited by 475
Faraone, S. V., Spencer, T., Aleardi, M., Pagano, C., & Biederman, J. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000108984.11879.95 · Cited by 404
Wolraich, M. L., Wibbelsman, C. J., Brown, T. E., Evans, S. W., Gotlieb, E. M., Knight, J. R., Ross, E. C., Shubiner, H. H., Wender, E. H., & Wilens, T. (2005) · Pediatrics · doi:10.1542/peds.2004-1959 · Cited by 404
Long-term Prognosis in Attention-Deficit/Hyperactivity Disorder
Mannuzza, S., & Klein, R. G. (2000) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/s1056-4993(18)30114-7 · Cited by 399
Cognitive deficits predict low treatment retention in cocaine dependent patients
Aharonovich, E., Hasin, D. S., Brooks, A. C., Liu, X., Bisaga, A., & Nunes, E. V. (2006) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.08.003 · Cited by 397
A Double-Blind, Placebo-Controlled Trial of Modafinil for Cocaine Dependence
Dackis, C. A., Kampman, K. M., Lynch, K. G., Pettinati, H. M., & O'Brien, C. P. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300600 · Cited by 391
Diagnostic Controversies in Adult Attention Deficit Hyperactivity Disorder
McGough, J. J., & Barkley, R. A. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.11.1948 · Cited by 388
Volkow, N. D., Wang, G.-J., Fowler, J. S., & Ding, Y.-S. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.006 · Cited by 368
Hesslinger, B., Tebartz van Elst, L., Nyberg, E., Dykierek, P., Richter, H., Berner, M., & Ebert, D. (2002) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-002-0379-0 · Cited by 366
Bupropion Hydrochloride in Attention Deficit Disorder with Hyperactivity
CONNERS, C. K., CASAT, C. D., GUALTIERI, C. T., WELLER, E., READER, M., REISS, A., WELLER, R. A., KHAYRALLAH, M., & ASCHER, J. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199610000-00018 · Cited by 342
Kessler, R. C., Adler, L., Ames, M., Barkley, R. A., Birnbaum, H., Greenberg, P., Johnston, J. A., Spencer, T., & ??st??n, T. B. (2005) · Journal of Occupational and Environmental Medicine · doi:10.1097/01.jom.0000166863.33541.39 · Cited by 335
Brain imaging of attention deficit/hyperactivity disorder
GIEDD, J. N., BLUMENTHAL, J., MOLLOY, E., & CASTELLANOS, F. X. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb05772.x · Cited by 331
Self-ratings of ADHD symptoms in adults I: Factor structure and normative data
Conners, C. K., Erhardt, D., Epstein, J. N., Parker, J. D. A., Sitarenios, G., & Sparrow, E. (1999) · Journal of Attention Disorders · doi:10.1177/108705479900300303 · Cited by 304
A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder
CONNOR, D. F., FLETCHER, K. E., & SWANSON, J. M. (1999) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199912000-00017 · Cited by 297
Diagnosis and evaluation of adults with attention-deficit/hyperactivity disorder
Adler, L., & Cohen, J. (2004) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2003.12.003 · Cited by 290
Prevalence of Attention-Deficit/Hyperactivity Disorder and Conduct Disorder Among Substance Abusers
Schubiner, H., Tzelepis, A., Milberger, S., Lockhart, N., Kruger, M., Kelley, B. J., & Schoener, E. P. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0402 · Cited by 282
Carroll, K. M., & Rounsaville, B. J. (1993) · Comprehensive Psychiatry · doi:10.1016/0010-440x(93)90050-e · Cited by 274
A Controlled Clinical Trial of Bupropion for Attention Deficit Hyperactivity Disorder in Adults
Wilens, T. E., Spencer, T. J., Biederman, J., Girard, K., Doyle, R., Prince, J., Polisner, D., Solhkhah, R., Comeau, S., Monuteaux, M. C., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.2.282 · Cited by 272
GREENHILL, L. L., HALPERIN, J. M., & ABIKOFF, H. (1999) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199905000-00011 · Cited by 268
Assessment and management of attention-deficit hyperactivity disorder in adults.
Weiss, M. D., & Murray, C. (2003) · Europe PMC (PubMed Central) · Cited by 265
A cognitive remediation programme for adults with Attention Deficit Hyperactivity Disorder
Stevenson, C. S., Whitmont, S., Bornholt, L., Livesey, D., & Stevenson, R. J. (2002) · Australian & New Zealand Journal of Psychiatry · doi:10.1046/j.1440-1614.2002.01052.x · Cited by 261
Barbaresi, W. J., Katusic, S. K., Colligan, R. C., Pankratz, V. S., Weaver, A. L., Weber, K. J., Mrazek, D. A., & Jacobsen, S. J. (2002) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.156.3.217 · Cited by 257
Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder
Biederman, J., Spencer, T., & Wilens, T. (2004) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145703003973 · Cited by 253
Spencer, T., Biederman, J., Wilens, T., Faraone, S., Prince, J., Gerard, K., Doyle, R., Parekh, A., Kagan, J., & Bearman, S. K. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.8.775 · Cited by 250
Schubiner, H., Downey, K. K., Arfken, C. L., Johanson, C.-E., Schuster, C. R., Lockhart, N., Edwards, A., Donlin, J., & Pihlgren, E. (2002) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.10.3.286 · Cited by 249
WILENS, T. E., GIGNAC, M., SWEZEY, A., MONUTEAUX, M. C., & BIEDERMAN, J. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000199027.68828.b3 · Cited by 246
Dextroamphetamine for Cocaine-Dependence Treatment: A Double-Blind Randomized Clinical Trial
Grabowski, J., Rhoades, H., Schmitz, J., Stotts, A., Daruzska, L. A., Creson, D., & Moeller, F. G. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200110000-00010 · Cited by 243
Kiyatkin, E. A., & Rebec, G. V. (1996) · Journal of Neurophysiology · doi:10.1152/jn.1996.75.1.142 · Cited by 243
Accuracy of Adult Recall of Childhood Attention Deficit Hyperactivity Disorder
Mannuzza, S., Klein, R. G., Klein, D. F., Bessler, A., & Shrout, P. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.11.1882 · Cited by 239
Levin, F. R., Evans, S. M., Brooks, D. J., & Garawi, F. (2007) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.07.004 · Cited by 220
Self-citationSpencer, T. J., Biederman, J., E. Ciccone, P., Madras, B. K., Dougherty, D. D., Bonab, A. A., Livni, E., Parasrampuria, D. A., & Fischman, A. J. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.3.387 · Cited by 206
Prevalence of adult attention-deficit hyperactivity disorder among cocaine abusers seeking treatment
Levin, F. R., Evans, S. M., & Kleber, H. D. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00049-0 · Cited by 199
Self-citationABIKOFF, H., HECHTMAN, L., KLEIN, R. G., GALLAGHER, R., FLEISS, K., ETCOVITCH, J., COUSINS, L., GREENFIELD, B., MARTIN, D., & POLLACK, S. (2004) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000128797.91601.1a · Cited by 198
Psychiatric syndromes in adolescent substance abusers
(1989) · American Journal of Psychiatry · doi:10.1176/ajp.146.9.1212 · Cited by 197
Wilens, T. E., Haight, B. R., Horrigan, J. P., Hudziak, J. J., Rosenthal, N. E., Connor, D. F., Hampton, K. D., Richard, N. E., & Modell, J. G. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.027 · Cited by 193
Replacement Medication for Cocaine Dependence: Methylphenidate
Grabowski, J., Roache, J. D., Schmitz, J. M., Rhoades, H., Creson, D., & Korszun, A. (1997) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199712000-00008 · Cited by 191
Taylor, F. B., & Russo, J. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200104000-00015 · Cited by 189
A double-blind, placebo-controlled trial of modafinil for cocaine dependence
Dackis, C. A., Kampman, K. M., Lynch, K. G., Plebani, J. G., Pettinati, H. M., Sparkman, T., & O'Brien, C. P. (2012) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2011.12.014 · Cited by 187
Grabowski, J., Rhoades, H., Stotts, A., Cowan, K., Kopecky, C., Dougherty, A., Moeller, F. G., Hassan, S., & Schmitz, J. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300392 · Cited by 185
TAYLOR, F. B., & RUSSO, J. (2000) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2000.10.311 · Cited by 180
Levin, F. R., Evans, S. M., Brooks, D. J., Kalbag, A. S., Garawi, F., & Nunes, E. V. (2006) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.06.012 · Cited by 173
Self-citationThompson, L. L., Riggs, P., Mikulich, S. K., & Crowley, T. J. (1996) · Research on Child and Adolescent Psychopathology · doi:10.1007/bf01441634 · Cited by 172
Wilens, T. E., Biederman, J., & Mick, E. (1998) · The American Journal on Addictions · doi:10.1111/j.1521-0391.1998.tb00330.x · Cited by 167
Levin, F. R., Evans, S. M., McDowell, D. M., & Kleber, H. D. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n0605 · Cited by 161
Self-citationGreenhill, L. L., Biederman, J., Boellner, S. W., Rugino, T. A., Sangal, R. B., Earl, C. Q., JIANG, J. G., & Swanson, J. M. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000205709.63571.c9 · Cited by 160
Adler, L. A., Spencer, T. J., Milton, D. R., Moore, R. J., & Michelson, D. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0304 · Cited by 157
Dual diagnosis and successful participation of adolescents in substance abuse treatment
Wise, B. K., Cuffe, S. P., & Fischer, T. (2001) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(01)00193-3 · Cited by 152
Ebstein, R. P., Nemanov, L., Klotz, I., Gritsenko, I., & Belmaker, R. H. (1997) · Molecular Psychiatry · doi:10.1038/sj.mp.4000333 · Cited by 143
Pilot randomized double blind placebo‐controlled study of dexamphetamine for cocaine dependence
Shearer, J., Wodak, A., Van Beek, I., Mattick, R. P., & Lewis, J. (2003) · Addiction · doi:10.1046/j.1360-0443.2003.00447.x · Cited by 141
Ernst, M., Luckenbaugh, D. A., Moolchan, E. T., Leff, M. K., Allen, R., Eshel, N., London, E. D., & Kimes, A. (2006) · Pediatrics · doi:10.1542/peds.2005-0704 · Cited by 137
CLINICAL USE OF RATING SCALES IN DIAGNOSIS AND TREATMENT OF ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
Conners, C. K. (1999) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(05)70159-0 · Cited by 135
Attention-Deficit/Hyperactivity Disorder and Substance Use: Symptom Pattern and Drug Choice
Clure, C., Brady, K. T., Saladin, M. E., Johnson, D., Waid, R., & Rittenbury, M. (1999) · The American Journal of Drug and Alcohol Abuse · doi:10.1081/ada-100101871 · Cited by 135
Comparison of acute behavioral effects of sustained-release and immediate-release methylphenidate.
Kollins, S. H., Rush, C. R., Pazzaglia, P. J., & Ali, J. A. (1998) · Experimental and Clinical Psychopharmacology · doi:10.1037//1064-1297.6.4.367 · Cited by 117
Levin, F., Evans, S., Vosburg, S., Horton, T. L., Brooks, D. J., & Ng, J. (2004) · Addictive Behaviours · doi:10.1016/j.addbeh.2004.03.041 · Cited by 116
Self-citationMethamphetamine self-administration by humans
Hart, C. L., Ward, A. S., Haney, M., Foltin, R. W., & Fischman, M. W. (2001) · Psychopharmacology · doi:10.1007/s002130100738 · Cited by 115
Rush, C. R., Essman, W. D., Simpson, C. A., & Baker, R. W. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200106000-00005 · Cited by 111
Swanson, J. M., Greenhill, L. L., Lopez, F. A., Sedillo, A., Earl, C. Q., Jiang, J. G., & Biederman, J. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0120 · Cited by 103
Bupropion Treatment for Cocaine Abuse and Adult Attention-Deficit/Hyperactivity Disorder
Levin, F. R., Evans, S. M., McDowell, D. M., Brooks, D. J., & Nunes, E. (2002) · Journal of Addictive Diseases · doi:10.1300/j069v21n02_01 · Cited by 102
Self-citationPilot randomized controlled study of dexamphetamine substitution for amphetamine dependence
Shearer, J., Wodak, A., Mattick, R. P., Van Beek, I., Lewis, J., Hall, W., & Dolan, K. (2001) · Addiction · doi:10.1046/j.1360-0443.2001.96912898.x · Cited by 93
Hechtman, L. T., Abikoff, H., Klein, R. G., Greenfield, B. J., Etcovitch, J., Cousins, L. S., Fleiss, K., Weiss, M. D., & Pollack, S. Z. (2004) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000128785.52698.19 · Cited by 78
Stoops, W. W., Glaser, P. E. A., Fillmore, M. T., & Rush, C. R. (2004) · Journal of Psychopharmacology · doi:10.1177/026988110401800411 · Cited by 75
White, A. M., Jordan, J. D., Schroeder, K. M., Acheson, S. K., Georgi, B. D., Sauls, G., Ellington, R. R., & Swartzwelder, H. S. (2004) · Substance Abuse · doi:10.1300/j465v25n01_08 · Cited by 74
OLVERA, R. L., PLISZKA, S. R., LUH, J., & TATUM, R. (1996) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.1996.6.241 · Cited by 73
RIGGS, P. D., & Jellinek, M. S. (1998) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199803000-00019 · Cited by 73
Gordon, S. M., Tulak, F., & Troncale, J. (2004) · Journal of Addictive Diseases · doi:10.1300/j069v23n04_03 · Cited by 67
Methylphenidate and Dextroamphetamine Abuse in Substance‐Abusing Adolescents
Williams, R. J., Goodale, L. A., Shay‐Fiddler, M. A., Gloster, S. P., & Chang, S. Y. (2004) · The American Journal on Addictions · doi:10.1080/10550490490483053 · Cited by 64
Biederman, J., Swanson, J. M., Wigal, S. B., Boellner, S. W., Earl, C. Q., Lopez, F. A., & Modafinil ADHD Study Group (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0506 · Cited by 58
Venlafaxine in children and adolescents with attention deficit hyperactivity disorder
MOTAVALLI MUKADDES, N., & ABALI, O. (2004) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2004.01199.x · Cited by 54
Somoza, E. C., Winhusen, T. M., Bridge, T. P., Rotrosen, J. P., Vanderburg, D. G., Harrer, J. M., Mezinskis, J. P., Montgomery, M. A., Ciraulo, D. A., Wulsin, L. R., et al. (2004) · Journal of Addictive Diseases · doi:10.1300/j069v23n01_07 · Cited by 53
Shenker, A. (1992) · Advances in Pediatrics · doi:10.1016/s0065-3101(24)00289-5 · Cited by 53
Greenhill, L. L., SWANSON, J. M., Steinhoff, K., FRIED, J., Posner, K., Lerner, M., Wigal, S. B., Clausen, S., Zhang, Y., & Tulloch, S. J. (2003) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200310000-00015 · Cited by 52
Dexamphetamine substitution in the treatment of amphetamine abuse: an initial investigation
White, R. (2000) · Addiction · doi:10.1046/j.1360-0443.2000.9522299.x · Cited by 49
Predicting substance abuse in juvenile offenders: Attention deficit disorder versus aggressivity
Halikas, J. A., Meller, J., Morse, C. L., & Lyttle, M. D. (1990) · Child Psychiatry & Human Development · doi:10.1007/bf00709927 · Cited by 45
Castañeda, R., Levy, R., Hardy, M., & Trujillo, M. (2000) · Psychiatric Services · doi:10.1176/appi.ps.51.2.169 · Cited by 39
Laboratory Measures of Methylphenidate Effects in Cocaine-Dependent Patients Receiving Treatment
Roache, J. D., Grabowski, J., Schmitz, J. M., Creson, D. L., & Rhoades, H. M. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200002000-00011 · Cited by 34
Assessing methylphenidate preference in ADHD patients using a choice procedure
Fredericks, E. M., & Kollins, S. H. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1838-2 · Cited by 30
Milin, R., Loh, E., Chow, J., & Wilson, A. (1997) · Psychiatric Services · doi:10.1176/ps.48.11.1378 · Cited by 26
Diagnosing Mental Disorders in Office-Based Pediatric Practice
Olfson, M. (1992) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/00004703-199210010-00008 · Cited by 22
Diagnosing mental disorders in office-based pediatric practice.
Olfson, M. (1992) · PubMed · Cited by 21
Ciccone, P. E. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200207000-00002 · Cited by 12
Research works printed but not linked: 5
- First MB, 1995, SCID‐I/P, Version 2.0.
- Swanson J., 1994, SNAP‐IV Scale
- Substance Abuse and Mental Health Services Administration, 2003, NHSDA Series H‐22, DHHS Publication No. SMA 03*3836
- 10.1177/0269881104047281 · doi:10.1177/0269881104047281 · Paper page
- 10.1037/1064-1297.6.4.367 · doi:10.1037/1064-1297.6.4.367 · Paper page
Cited by
Kooij, S. J., Bejerot, S., Blackwell, A., Caci, H., Casas-Brugué, M., Carpentier, P. J., Edvinsson, D., Fayyad, J., Foeken, K., Fitzgerald, M., et al. (2010) · BMC Psychiatry · doi:10.1186/1471-244x-10-67 · Cited by 928
“However, systematic research has not provided a strong evidence base for appreciable improvements in ADHD when treated in the presence of substance use disorders [255,256]; and drug or alcohol abuse disorders should always be targeted as a primary disorder.”
Castells, X., Ramos-Quiroga, J. A., Rigau, D., Bosch, R., Nogueira, M., Vidal, X., & Casas, M. (2011) · CNS Drugs · doi:10.2165/11539440-000000000-00000 · Cited by 197
Efficacy of Psychostimulant Drugs for Cocaine Dependence
Castells, X., Casas, M., Pérez-Mañá, C., Roncero, C., Vidal, X., & Capellà, D. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007380.pub3 · Cited by 130
Torrens, M., Rossi, P. C., Martinez-Riera, R., Martinez-Sanvisens, D., & Bulbena, A. (2012) · Substance Use & Misuse · doi:10.3109/10826084.2012.663296 · Cited by 122
“Recently, an interest has been developed with regard to ADHD’s co-morbidity with substance use (Mariani & Levin, 2007; Wilens & Biederman, 2006).”
BackgroundADHD in children and youth: Part 1—Etiology, diagnosis, and comorbidity
Bélanger, S. A., Andrews, D., Gray, C., & Korczak, D. J. (2018) · Paediatrics & Child Health · doi:10.1093/pch/pxy109 · Cited by 181
“The treatment of ADHD comorbid with a SUD is complicated by risks for misuse and diversion of prescription stimulants (59).”
Background
Metadata
- Authors
- Mariani, J. J., & Levin, F. R.
- Affiliations
- New York State Psychiatric Institute (US)
- Columbia University (US)
- Corresponding author
- Mariani, John J.
- Venue
- The American Journal on Addictions
- Publisher
- Wiley
- Published
- 2007-01-02
- Volume
- 16
- Issue
- s1
- Pages
- 45-56
- ISSN
- 1055-0496 (ISSN-L)
- 1521-0391
- PMC
- PMC2676785
- OpenAlex
- W2146314019
- Cited by
- 153
- References
- 110
- Citations by year
- 2026: 8 · 2025: 10 · 2024: 9 · 2023: 9 · 2022: 11 · 2021: 8 · 2020: 11 · 2019: 6 · 2018: 11 · 2017: 9 · 2016: 5 · 2015: 4 · 2014: 13 · 2013: 5 · 2012: 8
- FWCI
- 0.85
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- American Journal on Addictions (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Drug Abuse (K02DA00465, K02DA000465, K23DA021209)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Keywords
- attention deficit hyperactivity disorder, substance use disorders, comorbidities, psychostimulants, ADHD medication, psychotherapy, treatment planning, clinical management
- MeSH terms
- Attention Deficit Disorder with Hyperactivity, Child, Combined Modality Therapy, Drug Therapy, Humans, Psychotherapy, Comorbidity, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.